Biomea Fusion Inc (BMEA)

NASDAQ
10.87
+0.26(+2.50%)
  • Volume:
    57,243
  • Day's Range:
    10.55 - 11.03
  • 52 wk Range:
    2.84 - 14.85

BMEA Overview

Prev. Close
10.6
Day's Range
10.55-11.03
Revenue
-
Open
10.6
52 wk Range
2.84-14.85
EPS
-2.09
Volume
57,243
Market Cap
320.73M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
216,189
P/E Ratio
-5.24
Beta
-0.726
1-Year Change
-2.57%
Shares Outstanding
29,290,593
Next Earnings Date
Nov 02, 2022
What is your sentiment on Biomea Fusion?
or
Vote to see community's results!

Biomea Fusion Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Biomea Fusion Inc Company Profile

Biomea Fusion Inc Company Profile

Employees
72

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellBuy
Technical IndicatorsNeutralStrong BuyStrong SellSellNeutral
SummaryNeutralNeutralStrong SellSellNeutral